Jacobi Capital Management’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-3,064
Closed -$292K 634
2025
Q4
$292K Hold
3,064
0.02% 534
2025
Q3
$299K Buy
3,064
+20
+0.7% +$2.07K 0.02% 515
2025
Q2
$327K Hold
3,044
0.02% 481
2025
Q1
$307K Hold
3,044
0.02% 473
2024
Q4
$272K Sell
3,044
-21
-0.7% -$1.85K 0.02% 483
2024
Q3
$257K Buy
3,065
+65
+2% +$5.12K 0.02% 494
2024
Q2
$231K Hold
3,000
0.02% 471
2024
Q1
$205K Sell
3,000
-744
-20% -$47.8K 0.02% 460
2023
Q4
$216K Buy
+3,744
New +$200K 0.02% 435
2023
Q3
Sell
-3,744
Closed -$203K 432
2023
Q2
$203K Buy
+3,744
New +$196K 0.02% 423
2021
Q4
Sell
-3,000
Closed -$130K 538
2021
Q3
$130K Hold
3,000
0.02% 474
2021
Q2
$128K Sell
3,000
-900
-23% -$37.9K 0.02% 443
2021
Q1
$151K Sell
3,900
-458
-11% -$17.3K 0.02% 388
2020
Q4
$157K Buy
4,358
+1,058
+32% +$38.1K 0.02% 351
2020
Q3
$126K Hold
3,300
0.02% 356
2020
Q2
$116K Buy
3,300
+300
+10% +$10.8K 0.02% 349
2020
Q1
$98K Hold
3,000
0.02% 328
2019
Q4
$136K Hold
3,000
0.02% 330
2019
Q3
$122K Hold
3,000
0.02% 329
2019
Q2
$129K Hold
3,000
0.03% 322
2019
Q1
$115K Hold
3,000
0.03% 295
2018
Q4
$106K Hold
3,000
0.03% 287
2018
Q3
$116K Hold
3,000
0.03% 303
2018
Q2
$98K Buy
+3,000
New +$90.5K 0.03% 321

Other funds holding BSX

Jacobi Capital Management's BSX Position: Q1 2026 in Review

Jacobi Capital Management sold out of Boston Scientific (BSX) in Q1 2026, closing a stake of 3,064 shares — an estimated $292K sold.

Jacobi Capital Management first reported a position in BSX in Q2 2018 and held it in 24 quarters. The position peaked at $327K in Q2 2025. 1,664 funds tracked by Wall St. Rank hold BSX as of Q1 2026.

  • Jacobi Capital Management reported no remaining Boston Scientific position as of Q1 2026 after selling out during the quarter.
  • Jacobi Capital Management sold 3,064 Boston Scientific shares in Q1 2026, an estimated $292K.
  • Jacobi Capital Management first reported a position in Boston Scientific in Q2 2018 and held it in 24 quarters.
  • Jacobi Capital Management's Boston Scientific position peaked at $327K in Q2 2025.
  • 1,664 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2026.

Based on Jacobi Capital Management's 13F filing for Q1 2026, filed 14 May 2026.